Related Experiment Video
Updated: Feb 23, 2026

Monitoring Hippo Signaling Pathway Activity Using a Luciferase-based Large Tumor Suppressor LATS Biosensor
Published on: September 13, 2018
Mapping the STK4/Hippo signaling network in prostate cancer cell
Damien Ready1, Kader Yagiz2, Pooneh Amin3
1Department of Mathematics, Statistics, and Computer Science, Marquette University, Milwaukee, Wisconsin, United States of America.
Abstract:
Dysregulation of MST1/STK4, a key kinase component of the Hippo-YAP pathway, is linked to the etiology of many cancers with poor prognosis. However, how STK4 restricts the emergence of aggressive cancer remains elusive. Here, we investigated the effects of STK4, primarily localized in the cytoplasm, lipid raft, and nucleus, on cell growth and gene expression in aggressive prostate cancer. We demonstrated that lipid raft and nuclear STK4 had superior suppressive effects on cell growth in vitro and in vivo compared with cytoplasmic STK4. Using RNA sequencing and bioinformatics analysis, we identified several differentially expressed (DE) genes that responded to ectopic STK4 in all three subcellular compartments. We noted that the number of DE genes observed in lipid raft and nuclear STK4 cells were much greater than cytoplasmic STK4. Our functional annotation clustering showed that these DE genes were commonly associated with oncogenic pathways such as AR, PI3K/AKT, BMP/SMAD, GPCR, WNT, and RAS as well as unique pathways such as JAK/STAT, which emerged only in nuclear STK4 cells. These findings indicate that MST1/STK4/Hippo signaling restricts aggressive tumor cell growth by intersecting with multiple molecular pathways, suggesting that targeting of the STK4/Hippo pathway may have important therapeutic implications for cancer.
Insights
The Hippo-YAP pathway kinase STK4 restricts aggressive prostate cancer growth. Nuclear and lipid raft STK4 show stronger suppressive effects on cell growth and gene expression than cytoplasmic STK4.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Dysregulation of the MST1/STK4 kinase, a core component of the Hippo-YAP pathway, is implicated in aggressive cancers with poor prognoses.
- The precise mechanisms by which STK4 inhibits aggressive cancer development are not fully understood.
Purpose of the Study:
- To investigate the impact of STK4 localization (cytoplasmic, lipid raft, nuclear) on cell growth and gene expression in aggressive prostate cancer.
- To elucidate how STK4's subcellular positioning influences its tumor-suppressive functions.
Main Methods:
- Utilized RNA sequencing and bioinformatics analysis to identify differentially expressed genes in response to ectopic STK4 expression across different cellular compartments.
- Conducted in vitro and in vivo experiments to assess the effects of STK4 on aggressive prostate cancer cell growth.
Main Results:
- Lipid raft and nuclear STK4 exhibited significantly greater suppressive effects on cell growth compared to cytoplasmic STK4.
- Ectopic STK4 influenced gene expression across all three compartments, with lipid raft and nuclear localization affecting a larger number of genes.
- Differentially expressed genes were associated with key oncogenic pathways including AR, PI3K/AKT, BMP/SMAD, GPCR, WNT, and RAS. Nuclear STK4 uniquely modulated the JAK/STAT pathway.
Conclusions:
- MST1/STK4/Hippo signaling acts as a crucial suppressor of aggressive tumor cell proliferation by interacting with diverse molecular pathways.
- Targeting the STK4/Hippo pathway holds potential therapeutic implications for managing aggressive cancers.
Related Concept Videos
Hedgehog Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The JAK-STAT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

